The team tackled a critical challenge in treating multiple myeloma—a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients ...

The chances of getting it are 1 in 132. It’s more likely to affect men. Multiple myeloma can cause lesions on your bones, visible in imaging tests, that raise your risk of cracks or breaks.

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

[141] Bone disease is a hallmark of multiple myeloma (MM), associated with bone ... Osteolytic bone lesions are the result of excessive bone resorption due to increased osteoclast formation ...

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients ...

Myeloma develops due to the accumulation of multiple pathological genetic events ... chain variable region constitute primary genetic lesions. These primary lesions co-operate with secondary ...

has developed a new biomaterial with high potential in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone ...